The ErbaQik Sickle Cell Test is a competitive lateral flow assay that provides results in just 8–10 minutes without interference from fetal hemoglobin. This point-of-care solution is ideal for remote areas, offering clear differentiation between sickle cell disease and trait for individuals of all age groups.
- The test utilizes a competitive lateral flow assay format.
- It provides results in 8-10 minutes.
- The system allows for the differentiation between sickle cell disease and sickle cell trait.
- It is ideal for point-of-care testing in remote areas.
- There is no interference from fetal hemoglobin (HbF).
- The test is suitable for screening individuals of all age groups.
- The product is developed by Erba Mannheim and Transasia, India’s number one diagnostic company.
